Former CEO Pleads Guilty to Marketing Unapproved Medical Device
The former CEO of Utah-based device maker Dolor Technologies will be sentenced Nov. 8 on misdemeanor charges related to failure to seek FDA approval for a device to treat migraine headaches.
Source: Drug Industry Daily